Key deals this week: Amcor, ONEOK, Grifols, N-able and more
Packaging solutions company Amcor (AMCR) has agreed to acquire peer Berry Global Group (BERY) in an $8.4B all-stock ...
Sean Zam named Head of Sales and Marketing at GC Biopharma USA
GC Biopharma USA, the commercial operations and distribution company of GC Biopharma, has announced the appointment of ...
The Corner5d
Grifols believes Brookfield’s non-binding offer greatly undervalues fundamental prospects and long-term potential
Santander Credit Research | Grifols (B+ s, B+ s) yesterday informed the CNMV that it has received a non-binding offer from ...
GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
GIGA-2339 contains more than 1,000 fully human recombinant anti-HBV antibodies and is the first recombinant polyclonal ...
Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%
Per GRFS, Brookfield's offer to buy its entire outstanding share capital for 6.45 billion euros significantly undervalues GRFS' prospects and long-term potential.
FiercePharma6d
Plasma specialist Grifols shrugs off private equity firm Brookfield's potential €6.5B takeover offer
With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...
clinicaltrialsarena6d
GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment
GigaGen, a subsidiary of Grifols, has commenced a Phase I trial, with the first patient receiving a dose of GIGA-2339 aimed ...
Grifols Signals It Would Reject $6.8 Billion Brookfield Bid (3)
Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the ...